672 related articles for article (PubMed ID: 31894500)
1. Synergistic Effects of Efflux Pump Modulators on the Azole Antifungal Susceptibility of Microsporum canis.
Aneke CI; Rhimi W; Otranto D; Cafarchia C
Mycopathologia; 2020 Apr; 185(2):279-288. PubMed ID: 31894500
[TBL] [Abstract][Full Text] [Related]
2. The role of drug efflux pumps in Malassezia pachydermatis and Malassezia furfur defence against azoles.
Iatta R; Puttilli MR; Immediato D; Otranto D; Cafarchia C
Mycoses; 2017 Mar; 60(3):178-182. PubMed ID: 27774659
[TBL] [Abstract][Full Text] [Related]
3. Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
Aneke CI; Rhimi W; Otranto D; Cafarchia C
Mycopathologia; 2020 Jun; 185(3):495-502. PubMed ID: 32468154
[TBL] [Abstract][Full Text] [Related]
4. Linalool modulates dermatophyte susceptibility to azole drugs.
Ponte HAS; Lima MIO; Lima EO; Pereira FO
Med Mycol; 2020 Feb; 58(2):272-274. PubMed ID: 31329906
[TBL] [Abstract][Full Text] [Related]
5. Multi-azole-resistant strain of Malassezia pachydermatis isolated from a canine Malassezia dermatitis.
Kano R; Yokoi S; Kariya N; Oshimo K; Kamata H
Med Mycol; 2019 Apr; 57(3):346-350. PubMed ID: 29800467
[TBL] [Abstract][Full Text] [Related]
6. Potent synergic effect between ibuprofen and azoles on Candida resulting from blockade of efflux pumps as determined by FUN-1 staining and flow cytometry.
Pina-Vaz C; Rodrigues AG; Costa-de-Oliveira S; Ricardo E; Mårdh PA
J Antimicrob Chemother; 2005 Oct; 56(4):678-85. PubMed ID: 16115827
[TBL] [Abstract][Full Text] [Related]
7. Multi-azole-resistant strains of Cryptococcus neoformans var. grubii isolated from a FLZ-resistant strain by culturing in medium containing voriconazole.
Kano R; Okubo M; Hasegawa A; Kamata H
Med Mycol; 2017 Nov; 55(8):877-882. PubMed ID: 28927230
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
9. Cross-resistance to fluconazole induced by exposure to the agricultural azole tetraconazole: an environmental resistance school?
Rocha MF; Alencar LP; Paiva MA; Melo LM; Bandeira SP; Ponte YB; Sales JA; Guedes GM; Castelo-Branco DS; Bandeira TJ; Cordeiro RA; Pereira-Neto WA; Brandine GS; Moreira JL; Sidrim JJ; Brilhante RS
Mycoses; 2016 May; 59(5):281-90. PubMed ID: 26864989
[TBL] [Abstract][Full Text] [Related]
10. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
11. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
12. Increase in resistance to fluconazole and itraconazole in Trichophyton rubrum clinical isolates by sequential passages in vitro under drug pressure.
Hryncewicz-Gwóźdź A; Kalinowska K; Plomer-Niezgoda E; Bielecki J; Jagielski T
Mycopathologia; 2013 Aug; 176(1-2):49-55. PubMed ID: 23595653
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of promethazine on cell morphology and structure and mitochondrial activity of azole-resistant Candida tropicalis.
Brilhante RSN; de Oliveira JS; de Jesus Evangelista AJ; Pereira VS; Alencar LP; Castelo-Branco DSCM; Câmara LMC; de Lima-Neto RG; Cordeiro RA; Sidrim JJC; Rocha MFG
Med Mycol; 2018 Nov; 56(8):1012-1022. PubMed ID: 29420801
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Serrano-Martino Mdel C; Chávez-Caballero M; Valverde-Conde A; Claro RM; Pemán J; Martín-Mazuelos E
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):484-7. PubMed ID: 14572380
[TBL] [Abstract][Full Text] [Related]
15.
Gao L; Xia X; Gong X; Zhang H; Sun Y
Front Cell Infect Microbiol; 2024; 14():1296151. PubMed ID: 38304196
[TBL] [Abstract][Full Text] [Related]
16. Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Pujol I; Capilla J; Fernández-Torres B; Ortoneda M; Guarro J
J Clin Microbiol; 2002 Jul; 40(7):2618-21. PubMed ID: 12089289
[TBL] [Abstract][Full Text] [Related]
17. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Simonetti O; Silvestri C; Arzeni D; Cirioni O; Kamysz W; Conte I; Staffolani S; Orsetti E; Morciano A; Castelli P; Scalise A; Kamysz E; Offidani AM; Giacometti A; Barchiesi F
Mycoses; 2014 Apr; 57(4):233-9. PubMed ID: 26058322
[TBL] [Abstract][Full Text] [Related]
20. The best type of inoculum for testing the antifungal drug susceptibility of Microsporum canis: In vivo and in vitro results.
Aneke CI; Rhimi W; Pellicoro C; Cantacessi C; Otranto D; Cafarchia C
Mycoses; 2020 Jul; 63(7):711-716. PubMed ID: 32299129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]